Searchable abstracts of presentations at key conferences in endocrinology

ea0034p278 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Therapeutic durability of the GLP1-based therapy Liraglutide in patients with type 2 diabetes mellitus

Border Daniel , Clayton Wendy , Thadani Puja , Reed Joseph , Randeva Harpal , Barber Thomas

Introduction: Therapeutic durability of GLP1-based therapies in patients with type 2 diabetes mellitus (T2D) is incompletely understood. Our aim was to explore the therapeutic effects of GLP1 based therapies in patients with T2D.Methods: This was a retrospective study on patients with T2D (n=55) who attend a specialist clinic at UHCW, Coventry, and who had been treated with the GLP1 based therapy, Liraglutide, for at least 6 months. A successful...

ea0070aep86 | Adrenal and Cardiovascular Endocrinology | ECE2020

VDR-GR complex reduces apoptosis in acute myeloid leukemia cells via reduction of GR transcriptional activity

Karapanagioti Angeliki , Nasiri-Ansari Narjes , Kalotychou Vasiliki , Lembesis Panayiotis , Randeva Harpal , Papavassiliou Athanasios G , Kassi Evanthia

Introduction: Glucocroticoids (GCs) which are routinely used in the treatment of Acute Lymphocytic Leukemia (ALL), found recently to be beneficial in a subset of AML patients resistant to chemotherapy, by promoting leukemia cells apoptosis. Current studies indicate that vitamin D (VitD) deficiency is highly prevalent among AML patients, posing vitamin D as a therapeutic supplementation. Our previous study demonstrated that VitD exerts inhibitory effect on Dexamethasone-induced...

ea0031p126 | Clinical practice/governance and case reports | SFEBES2013

Title: A case of primary hypoadrenalism secondary to amyloidosis

Watkins John , Verran Alice , Aftab Saboor , Randeva Harpal , Barber Tom , Reddy Narendra

Introduction: Endocrinopathy is frequently seen in systemic amyloidosis and commonly involves thyroid and gonads. We report a case of primary adrenal failure secondary to systemic light chain amyloidosis (AL), involving kidney, liver, spleen, gut, nerves and tongue.Case: A 42-year-old Somalian lady presented with 2-year history of lethargy, febrile episodes and 21 kg weight loss. Investigations showed increase in serum lambda light chain 103 mg/l (5.7&#1...

ea0028p100 | Clinical practice/governance and case reports | SFEBES2012

A case of unrecognized maternal PTH resistance and severe impact on neonatal bone mineralisation

Sivaraman Subash , Rao Ranganath , Murthy Narasimha , Weickhert Mi , Randeva Hs , Sankaranarayanan Sailesh , Harrold Christopher

A 25 year old lady was referred to the endocrine clinic after her newborn baby was noted to have respiratory problems, marked osteopenia and hypocalcemia. Further investigations on the mother showed corrected calcium of 1.11 mmol/L; however she was relatively asymptomatic. Reviewing her history in detail, she was born in Nigeria and moved to the UK 2 years prior to the presentation. She used to get intermittent cramps in her hands, legs and body since the age of 10 in addition...

ea0028p167 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

The Hepatokine Fetuin-A is increased in PCOS women. Association with metabolic syndrome and regulation by metformin

Aghilla Mohamed , Adya Raghu , Tan Bee , Lehnert Hendrik , Ashawesh Khaled , Randeva Harpal

Introduction: Polycystic Ovary Syndrome (PCOS) is associated with insulin resistance, visceral obesity -metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD). Fetuin-A, human protein: α2-Heremans-Schmid glycoprotein is an abundant serum protein exclusively expressed in the liver and has been suggested to act as a link between obesity, insulin resistance (IR), and MS.Aims: A) To determine levels of Fetuin-A in PCOS women. B) To invest...

ea0021p93 | Clinical practice/governance and case reports | SFEBES2009

Reasons for treatment changes in hypogonadal men undergoing testosterone replacement

Dutton David , Outterside Kate , Padinjakara Rayin , Weickert Martin , Randeva Harpal , Sankar Sailesh

Aims: Treatment regimes for low testosterone are well established but reasons for treatment change and patient preferences are less well known. We looked at the type of testosterone replacement, subsequent modification of replacement and reason for that change.Methods: Data were collected from the electronic case notes of 50 patients on testosterone replacement for at least 6 months attending endocrine clinics in a University Teaching Hospital.<p cla...

ea0021p132 | Diabetes and metabolism | SFEBES2009

Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices

Lewandowski Krzysztof , Cypryk Katarzyna , Nadel Iwona , Lewinski Andrzej , Bienkiewicz Malgorzata , Tan Bee , Randeva Harpal

Background: Gestational diabetes (GDM) is characterized by insulin resistance and a pro-inflammatory state, both factors possible related to adipokine expression. In our study we have endeavoured to assess serum levels of insulin-sensitising omentin and pro-inflammatory thrombospondin-1 (TSP-1) in GDM.Subjects and methods: The study included 20 women with GDM, diagnosed according to the WHO criteria, age 29.7±5.5 (mean±S.D.), BMI...

ea0021p153 | Diabetes and metabolism | SFEBES2009

A role for aquaglyceroporins in adipogenesis

Brown James , Conner Matthew , Bill Roslyn , Ramanjaneya Manjunath , Bailey Clifford , Randeva Harpal , Conner Alex

Aims/objectives: Glycerol cycling plays an essential regulatory role in metabolism in both health and disease. Aquaporins (AQPs) are a recently described family of water transporting membrane proteins, which contain a subset of members that also have the ability to transport glycerol across the cell membrane. This study sought to investigate the adipose tissue expression profile of AQPs in humans, and to assess the role of AQPs in adipocyte differentiation.<p class="abstex...

ea0019oc7 | Young Endocrinologist prize session | SFEBES2009

In vivo and ex vivo regulation of Visfatin production by leptin in human and murine adipose tissue: role of the PI3K and MAPK pathways

Tan Bee , Chen Jing , Brown James , Adya Raghu , Ramanjaneya Manjunath , Bailey Cliff , Lehnert Hendrik , Randeva Harpal

Apart from its role in energy storage, adipose tissue produces several hormones and cytokines termed ‘adipokines’ that have wide-ranging effects on carbohydrate and lipid metabolism; and thereby, play an important role in the pathogenesis of the metabolic syndrome. Visfatin is a novel adipokine, levels of which increase in obesity and is adipogenic; properties common to that of leptin. Thus, leptin may modulate visfatin production in adipose tissue. We investigated t...

ea0019p126 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Visfatin regulates insulin secretion and insulin receptor phosphorylation in a clonal beta-cell line

Brown J , Onyango D , Conner A , Ramanjaneya M , Dunmore S , Randeva H

Visfatin is a controversial molecule secreted from adipose tissue and known to be positively correlated with body mass. Previous reports have suggested that visfatin interacts with the insulin receptor signalling pathway. Due to its high expression in visceral fat tissue and its initial reported insulin sensitising effects it has been suggested to be involved in the pathogenesis of type 2 diabetes, although this link has yet to be well established. Since insulin receptors are ...